Cargando…

What's new in multiple sclerosis?

INTRODUCTION: Multiple sclerosis (MS) is a chronic disease state that affects and disables many people each year. The most common clinical presentation is relapsing-remitting MS (RRMS). In the past 7 years, new medications have been approved for the treatment of RRMS, thereby providing more treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tillery, Erika E., Clements, Jennifer N., Howard, Zach
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	College of Psychiatric & Neurologic Pharmacists 2018
Materias:	Review of Drugs/Pharmacotherapy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007716/ https://www.ncbi.nlm.nih.gov/pubmed/29955526 http://dx.doi.org/10.9740/mhc.2017.09.213

Ejemplares similares

Brexpiprazole: A review of a new treatment option for schizophrenia and major depressive disorder
por: Diefenderfer, Lauren A., et al.
Publicado: (2018)

Retracing our steps to understand ketamine in depression: A focused review of hypothesized mechanisms of action
por: Irwin, Madison N., et al.
Publicado: (2021)

Istradefylline: A novel agent in the treatment of “off” episodes associated with levodopa/carbidopa use in Parkinson disease
por: Cummins, Lauren, et al.
Publicado: (2022)

Pharmacogenetics of antiepileptic drugs: A brief review
por: Parker, D., et al.
Publicado: (2016)

Kappa opioid receptor antagonism: Are opioids the answer for treatment resistant depression?
por: Peckham, Alyssa M., et al.
Publicado: (2018)

Role of antidepressants in the treatment of adults with anorexia nervosa
por: Marvanova, Marketa, et al.
Publicado: (2018)

Pharmacokinetic characteristics of antiepileptic drugs (AEDs)
por: Marvanova, Marketa
Publicado: (2016)

A review of significant pharmacokinetic drug interactions with antidepressants and their management
por: Hoffelt, Charity, et al.
Publicado: (2016)

A review of pharmacokinetic and pharmacodynamic interactions with antipsychotics
por: Wijesinghe, Ruki
Publicado: (2016)

A review of citalopram dose restrictions in the treatment of neuropsychiatric disorders in older adults
por: McCarrell, Jamie L., et al.
Publicado: (2019)

Opioid antagonists to prevent olanzapine-induced weight gain: A systematic review
por: Laguado, S. Andrea, et al.
Publicado: (2022)

Effect of the new 75-mg orodispersible film of sildenafil on erection and sexual quality of life: insights from an observational study
por: Sansone, Andrea, et al.
Publicado: (2023)

STOMp: sexual function trial of overactive bladder medication
por: Polland, Allison, et al.
Publicado: (2023)

The availability of gonadotropin therapy from FDA-approved pharmacies for men with hypogonadism and infertility
por: Borgert, Benjamin J, et al.
Publicado: (2023)

Safety and Tolerability of Evening Ethanol Consumption and Bedtime Administration of Flibanserin in Healthy Premenopausal Female Subjects
por: Millheiser, Leah, et al.
Publicado: (2019)

A Practical Guide for Cardiologists to the Pharmacological Treatment of Patients with Type 2 Diabetes and Cardiovascular Disease
por: Ahmad, Tariq, et al.
Publicado: (2021)

Early Australian experience in the maintenance of schizophrenia management with 3-monthly paliperidone palmitate
por: Pai, Nagesh, et al.
Publicado: (2018)

Effectiveness of Omalizumab in Severe Allergic Asthma: A Retrospective UK Real-World Study
por: Barnes, Neil, et al.
Publicado: (2013)

Twelve- and 52-week safety of albuterol multidose dry powder inhaler in patients with persistent asthma
por: Raphael, Gordon, et al.
Publicado: (2016)

Endothelial Dysfunction in Patients With Erectile Dysfunction: A Double-Blind, Randomized-Control Trial Using Tadalafil
por: Pattanaik, Smita, et al.
Publicado: (2019)

Cardiovascular Imaging and Theranostics in Cardiovascular Pharmacotherapy
por: Cattaneo, Mattia, et al.
Publicado: (2019)

AF in Cancer Patients: A Different Need for Anticoagulation?
por: Sanz, Ana Pardo, et al.
Publicado: (2019)

Recent Warnings about Antihypertensive Drugs and Cancer Risk: Where Do They Come From?
por: Battistoni, Allegra, et al.
Publicado: (2020)

Testosterone Management in Aging Males: Surveying Clinical Practices of Urologists and Endocrinologists in Israel
por: Ishay, Avraham, et al.
Publicado: (2019)

Antithrombotic Treatment After Coronary Intervention: Agreement and Controversy
por: Camarero, Tamara García, et al.
Publicado: (2020)

Antithrombotic Therapy After Transcatheter Aortic Valve Implantation
por: Lugo, Leslie Marisol, et al.
Publicado: (2020)

Will Direct Oral Anticoagulants Have a Chance in Prosthetic Valves?
por: Abdelnabi, Mahmoud, et al.
Publicado: (2020)

The Daily Therapy With L-Arginine 2,500 mg and Tadalafil 5 mg in Combination and in Monotherapy for the Treatment of Erectile Dysfunction: A Prospective, Randomized Multicentre Study
por: Gallo, Luigi, et al.
Publicado: (2020)

Effect of Icariside II and Metformin on Penile Erectile Function, Histological Structure, Mitochondrial Autophagy, Glucose-Lipid Metabolism, Angiotensin II and Sex Hormone in Type 2 Diabetic Rats With Erectile Dysfunction
por: Zhang, Jian, et al.
Publicado: (2020)

The Effect of Food on the Pharmacokinetics of Buspirone After Single Administration of a Sublingual Testosterone and Oral Buspirone Combination Tablet in Healthy Female Subjects
por: Gerritsen, Jeroen, et al.
Publicado: (2020)

D-53 | Impact of Cardiovascular Diseases, Calcium Channel Blockers and Beta-Blockers on Mortality of Patients Hospitalized with COVID-19
por: Alhusain, Rashid, et al.
Publicado: (2022)

Efficacy and safety outcomes of a compounded testosterone pellet versus a branded testosterone pellet in men with testosterone deficiency: a single-center, open-label, randomized trial
por: Kresch, Eliyahu, et al.
Publicado: (2023)

Perspectives and Future Directions of Anticoagulant Therapy in Coronary Artery Disease Patients
por: Komiyama, Maki, et al.
Publicado: (2023)

Nuclear Factor-κB is a Prime Candidate for the Diagnosis and Control of Inflammatory Cardiovascular Disease
por: Matsumori, Akira
Publicado: (2023)

Carotid artery intima media thickness can predict the response to phosphodiesterase 5 inhibitors in patients with moderate erectile dysfunction
por: Kilic, Metin, et al.
Publicado: (2023)

Validating the Prognostic Utility of the ABCD-GENE Score in Asian Patients with Acute Coronary Syndrome Patients on Clopidogrel
por: Tan, Cheng Keat, et al.
Publicado: (2023)

Safety profile and signal detection of phosphodiesterase type 5 inhibitors for erectile dysfunction: a Food and Drug Administration Adverse Event Reporting System analysis
por: Shin, Young Eun, et al.
Publicado: (2023)

Review of pharmacotherapy for smoking cessation in patients with schizophrenia
por: Shawen, Avery E., et al.
Publicado: (2018)

Personalised Approaches to Improving the Effect of Anti-platelet Agents: Where Do We Stand?
por: Godoy, Lucas C, et al.
Publicado: (2019)

Cardiovascular Pharmacotherapy Focus
por: Avanzas, Pablo
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_l5mu3jgltvo8si50na4uqvnn9m